Experts Continue Evaluating Benefits and Risks of GLP-1 Agonists
A new tailored approach to using GLP-1 receptor agonists for obesity management achieves nearly twice the weight loss.
Unlocking the Potential of GLP-1 Agonists Beyond Diabetes and Weight Loss
The pharmaceutical industry is eagerly investigating new applications for GLP-1s, but the real opportunity lies in precision medicine.
Childhood Obesity Specialists Struggle to Get GLP-1 Agonists
Here are the challenges faced by pediatric obesity specialists in accessing weight-loss meds approved by the FDA for weight loss in kids 12 years or older.
Do I Have to Take a GLP-1 Medication Forever?
Must you take your GLP-1 medication forever to avoid weight gain and other adverse effects? Here’s what you need to know about them and life after them.
The “Miracle Drugs” Are Not Without Risk
While GLP-1RA medications offer broad health benefits, one recent study underscores that they are not without risks.
What Doctors Say About Prescribing GLP-1 Receptor Agonists to Kids
How often do doctors prescribe new weight loss drugs to kids? And what reservations and considerations drive their decisions?
Gene Therapy for Childhood Obesity
One recent study found that gene therapy converts Omega-6 to Omega-3 fatty acids in the body, in other words, turning “harmful fats” into “helpful fats.”
Natural Rivals to Ozempic?
Sometimes another substance can fill the same function as a natural chemical, in which case it is called a Receptor Agonist.
How Are Weight Loss Medications Covered Globally?
Europe and the U.S. consider whether to provide coverage for GLP-1 agonists.
Best Practices in Childhood Obesity Weight Management
Pediatric obesity experts agree that behavioral interventions, used in conjunction with GLP-1 medications, can be more effective than a standalone tool.